formosanin c has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LL; Lee, JC; Su, CL; Won, SJ | 1 |
| Bai, P; Bui-Nguyen, TM; Chen, X; Gao, L; Liu, J; Liu, S; Wang, H; Xiao, J; Xiao, X; Zhang, X; Zou, J | 1 |
2 other study(ies) available for formosanin c and cytochrome c-t
| Article | Year |
|---|---|
Formosanin C-induced apoptosis requires activation of caspase-2 and change of mitochondrial membrane potential.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase 2; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Cytochromes c; Diosgenin; DNA Fragmentation; Enzyme Activation; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Saponins | 2009 |
Paris saponin II of Rhizoma Paridis--a novel inducer of apoptosis in human ovarian cancer cells.
Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Diosgenin; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Flow Cytometry; Humans; Mice; Ovarian Neoplasms; Phosphorylation; Rhizome; Saponins; Xenograft Model Antitumor Assays | 2012 |